Position
CITIGROUP INC in DiaMedica Therapeutics Inc.
Back to the book · All holders of DMAC
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark −$1.03K$7.96 → $6.77
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 864 | $6.88K | — | — | — | 0.0% |
| Q1 2026 | 1.9K | $12.8K | $6.77 | −$1.03K | $6.99K | 0.0% |